CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
SleepFlexdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04726514
NCT04726514N/ACompleted

SleepFlexTM Treatment of Obstructive Sleep Apnea

Berendo Scientific, LLC·interventional·Posted Jan 27, 2021·Updated Jun 22, 2023

In Brief

A clinical study evaluating SleepFlex for Obstructive Sleep Apnea. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the safety and effectiveness of the SleepFlex program for treatment of mild to moderate OSA

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJan 27, 2021
Enrollment StartJul 20, 2021
Primary CompletionApr 1, 2022
Study CompletionMay 31, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 5.4 years ago

Interventions

SleepFlexdevice

SleepFlex Program